B. D. Kantamaneni

1.2k total citations
31 papers, 1.0k citations indexed

About

B. D. Kantamaneni is a scholar working on Cellular and Molecular Neuroscience, Neurology and Biological Psychiatry. According to data from OpenAlex, B. D. Kantamaneni has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 6 papers in Biological Psychiatry. Recurrent topics in B. D. Kantamaneni's work include Neuroscience and Neuropharmacology Research (10 papers), Tryptophan and brain disorders (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). B. D. Kantamaneni is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Tryptophan and brain disorders (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). B. D. Kantamaneni collaborates with scholars based in United Kingdom, Mexico and Ireland. B. D. Kantamaneni's co-authors include G. Curzon, G. S. Sarna, Peter H. Hutson, John R. Bartlett, Rebecca J. Williams, A. R. Davidson, A.J. Knell, Mark D. Tricklebank, R B Godwin-Austen and John Cavanagh and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

B. D. Kantamaneni

30 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. D. Kantamaneni United Kingdom 21 419 210 171 165 152 31 1.0k
U. Tossman Sweden 13 725 1.7× 183 0.9× 420 2.5× 180 1.1× 102 0.7× 15 1.2k
G. S. Sarna United Kingdom 24 962 2.3× 317 1.5× 648 3.8× 264 1.6× 180 1.2× 38 1.9k
A. T. B. Moir United Kingdom 10 502 1.2× 178 0.8× 208 1.2× 120 0.7× 154 1.0× 20 958
Johannes Wildmann Germany 14 401 1.0× 147 0.7× 236 1.4× 191 1.2× 48 0.3× 29 858
Gisele Hansel Brazil 19 306 0.7× 137 0.7× 281 1.6× 179 1.1× 78 0.5× 45 993
Benjamin F. Gruenbaum United States 24 418 1.0× 275 1.3× 362 2.1× 223 1.4× 127 0.8× 91 1.5k
Rocco Raffaele Italy 13 193 0.5× 117 0.6× 118 0.7× 45 0.3× 111 0.7× 22 568
Matthew Boyko Israel 24 463 1.1× 319 1.5× 416 2.4× 258 1.6× 122 0.8× 95 1.7k
Huda Khaldy Spain 15 280 0.7× 116 0.6× 474 2.8× 384 2.3× 79 0.5× 18 1.6k
I J Kopin United States 15 278 0.7× 56 0.3× 251 1.5× 195 1.2× 60 0.4× 26 829

Countries citing papers authored by B. D. Kantamaneni

Since Specialization
Citations

This map shows the geographic impact of B. D. Kantamaneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. D. Kantamaneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. D. Kantamaneni more than expected).

Fields of papers citing papers by B. D. Kantamaneni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. D. Kantamaneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. D. Kantamaneni. The network helps show where B. D. Kantamaneni may publish in the future.

Co-authorship network of co-authors of B. D. Kantamaneni

This figure shows the co-authorship network connecting the top 25 collaborators of B. D. Kantamaneni. A scholar is included among the top collaborators of B. D. Kantamaneni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. D. Kantamaneni. B. D. Kantamaneni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarna, G. S., B. D. Kantamaneni, & G. Curzon. (1985). Variables Influencing the Effect of a Meal on Brain Tryptophan. Journal of Neurochemistry. 44(5). 1575–1580. 27 indexed citations
2.
Hutson, Peter H., G. S. Sarna, B. D. Kantamaneni, & G. Curzon. (1985). Monitoring the Effect of a Tryptophan Load on Brain Indole Metabolism in Freely Moving Rats by Simultaneous Cerebrospinal Fluid Sampling and Brain Dialysis. Journal of Neurochemistry. 44(4). 1266–1273. 105 indexed citations
5.
Tricklebank, Mark D., David L. Bloxam, B. D. Kantamaneni, & G. Curzon. (1981). Brain 5-hydroxytryptamine metabolism after portocaval anastomosis: Relationship with ambulation. Pharmacology Biochemistry and Behavior. 14(2). 259–262. 21 indexed citations
6.
Gillman, Peter Kenneth, John R. Bartlett, P. K. Bridges, et al.. (1981). Indolic Substances in Plasma, Cerebrospinal Fluid, and Frontal Cortex of Human Subjects Infused with Saline or Tryptophan. Journal of Neurochemistry. 37(2). 410–417. 55 indexed citations
8.
Kantamaneni, B. D., et al.. (1980). SUBSTANCES RELATED TO 5‐HYDROXYTRYPTAMINE IN PLASMA AND IN LUMBAR AND VENTRICULAR FLUIDS OF PSYCHIATRIC PATIENTS. Acta Psychiatrica Scandinavica. 61(S280). 3–20. 33 indexed citations
9.
Gillman, Peter Kenneth, John R. Bartlett, P. K. Bridges, B. D. Kantamaneni, & G. Curzon. (1980). Relationships between tryptophan concentrations in human plasma, cerebrospinal fluid and cerebral cortex following tryptophan infusion. Neuropharmacology. 19(12). 1241–1242. 9 indexed citations
10.
Gentil, Valentim, M Lader, B. D. Kantamaneni, & G. Curzon. (1977). Effects of Adrenaline Injection on Human Plasma Tryptophan and Non-Esterified Fatty Acids. Clinical Science. 53(3). 227–232. 18 indexed citations
11.
Curzon, G. & B. D. Kantamaneni. (1977). Fluorimetric determination of plasma unesterified fatty acid. Clinica Chimica Acta. 76(2). 289–292. 10 indexed citations
12.
Curzon, G., B. D. Kantamaneni, John R. Bartlett, & P. K. Bridges. (1976). Transmitter precursors and metabolites in human ventricular cerebrospinal fluid. Journal of Neurochemistry. 26(3). 613–615. 30 indexed citations
13.
Bridges, P. K., et al.. (1976). Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients. Psychological Medicine. 6(3). 399–405. 32 indexed citations
14.
Knell, A.J., A. R. Davidson, Rebecca J. Williams, B. D. Kantamaneni, & G. Curzon. (1974). Dopamine and Serotonin Metabolism in Hepatic Encephalopathy. BMJ. 1(5907). 549–551. 120 indexed citations
15.
Parkes, J. D., Garry Fenton, G. Curzon, et al.. (1974). Narcolepsy and Cataplexy. Clinical Features, Treatment and Cerebrospinal Fluid Findings. QJM. 13 indexed citations
16.
Parkes, J. D., C. D. Marsden, G. Curzon, et al.. (1974). Parkinson's Disease, Cerebral Arteriosclerosis, and Senile Dementia<subtitle>CLINICAL FEATURES AND RESPONSE TO LEVODOPA</subtitle>. QJM. 43(169). 49–61. 48 indexed citations
17.
Clavería, L. E., G. Curzon, M J Harrison, & B. D. Kantamaneni. (1974). Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 37(6). 715–718. 57 indexed citations
18.
Hunter, Rachael, et al.. (1971). Effect of folic acid by mouth on cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentration. Journal of Neurology Neurosurgery & Psychiatry. 34(5). 571–575. 7 indexed citations
19.
Curzon, G., et al.. (1970). Thecerebrospinal fluid homovanillic acid concentration inpatients withParkinsonism treated withL-dopa.
20.
Curzon, G., et al.. (1970). The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.. Journal of Neurology Neurosurgery & Psychiatry. 33(1). 1–6. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026